NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 238 filers reported holding NEOGENOMICS INC in Q1 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $723,000 | -14.0% | 84,007 | -18.5% | 0.01% | 0.0% |
| Q2 2022 | $841,000 | -8.5% | 103,132 | +36.4% | 0.01% | +16.7% |
| Q1 2022 | $919,000 | -51.4% | 75,592 | +36.4% | 0.01% | -40.0% |
| Q4 2021 | $1,891,000 | +647.4% | 55,408 | +955.6% | 0.01% | +400.0% |
| Q3 2021 | $253,000 | -30.7% | 5,249 | -35.1% | 0.00% | 0.0% |
| Q2 2021 | $365,000 | -23.2% | 8,089 | -18.0% | 0.00% | -33.3% |
| Q1 2021 | $475,000 | -79.9% | 9,859 | -77.5% | 0.00% | -80.0% |
| Q4 2020 | $2,363,000 | +60.1% | 43,894 | +9.7% | 0.02% | +36.4% |
| Q3 2020 | $1,476,000 | +10.0% | 40,010 | -7.6% | 0.01% | +10.0% |
| Q2 2020 | $1,342,000 | +22.9% | 43,309 | +9.5% | 0.01% | -9.1% |
| Q1 2020 | $1,092,000 | -17.7% | 39,560 | -12.8% | 0.01% | +10.0% |
| Q4 2019 | $1,327,000 | +31.8% | 45,351 | -13.9% | 0.01% | +25.0% |
| Q3 2019 | $1,007,000 | -46.0% | 52,674 | -38.0% | 0.01% | -46.7% |
| Q2 2019 | $1,866,000 | +12.7% | 85,009 | +5.0% | 0.02% | +15.4% |
| Q1 2019 | $1,656,000 | +258.4% | 80,938 | +120.8% | 0.01% | +225.0% |
| Q4 2018 | $462,000 | -21.7% | 36,655 | -4.6% | 0.00% | 0.0% |
| Q3 2018 | $590,000 | +13.9% | 38,421 | -3.0% | 0.00% | +33.3% |
| Q2 2018 | $518,000 | +55.1% | 39,613 | -3.4% | 0.00% | +200.0% |
| Q1 2018 | $334,000 | -4.8% | 41,001 | +3.9% | 0.00% | 0.0% |
| Q4 2017 | $351,000 | +17.4% | 39,457 | +46.6% | 0.00% | 0.0% |
| Q3 2017 | $299,000 | +247.7% | 26,919 | +159.3% | 0.00% | – |
| Q3 2016 | $86,000 | -61.3% | 10,382 | -62.3% | 0.00% | -100.0% |
| Q2 2016 | $222,000 | +43.2% | 27,529 | +19.5% | 0.00% | – |
| Q1 2016 | $155,000 | -52.5% | 23,041 | -44.5% | 0.00% | -100.0% |
| Q4 2015 | $326,000 | +379.4% | 41,544 | +247.9% | 0.00% | – |
| Q3 2015 | $68,000 | -1.4% | 11,940 | -7.4% | 0.00% | – |
| Q2 2015 | $69,000 | +27.8% | 12,894 | -21.1% | 0.00% | – |
| Q2 2014 | $54,000 | -28.9% | 16,343 | -25.7% | 0.00% | – |
| Q1 2014 | $76,000 | +20.6% | 21,992 | +27.1% | 0.00% | – |
| Q4 2013 | $63,000 | +34.0% | 17,300 | +10.6% | 0.00% | – |
| Q3 2013 | $47,000 | – | 15,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |